Skip to main content

quetiapine

Generic: QUETIAPINE FUMARATE·Brand: QUETIAPINE FUMARATE, SEROQUEL, SEROQUEL XR, Seroquel

quetiapine: 3 clinical trials tracked.

quetiapine evidence translation

What we can confirm

3 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about quetiapine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 2 study sponsors
Clinical Trials (3)

Efficacy and Safety of Acute Followed by Maintenance rTMS in Treatment Resistant Depression: A Randomized Controlled Trial

NCT07760168·Phase 3
Not yet recruiting

Primary endpoint: To compare the efficacy of maintenance accelerated intermittent theta burst stimulation vs Quetiapine on symptomatology in terms of change in MADRS score in patients with treatment resistance depression

InterventionalRandomizedopen68 targetStarted 2026-08Completion 2028-08All India Institute of Medical Sciences, Bhubaneswar

A Pilot Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine

NCT04164758·Phase 2·ACAD
Terminated

Primary endpoint: Treatment-emergent Adverse Events (TEAEs)

InterventionalRandomizedquadruple11 targetStarted 2019-10Completion 2020-0916 sites · United StatesACADIA Pharmaceuticals Inc.

A Prospective, Matched-Control, Randomized, Open-Label, Flexible-Dose, Study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics

NCT02431702·Phase 3·BRSF
Completed

Primary endpoint: Part-2 (Disease Progression): Time to First Treatment Failure

InterventionalRandomizedopen337 enrolledStarted 2015-07Completion 2019-1138 sites · Brazil, Mexico, United StatesJanssen Scientific Affairs, LLC